Active Ingredient: ABACAVIR SULFATE; LAMIVUDINE
Proprietary Name: ABACAVIR SULFATE AND LAMIVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE;300MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A091144
Product Number: 001
Approval Date: Mar 28, 2017
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
